133 related articles for article (PubMed ID: 21258428)
1. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
2. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.
Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S
Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
Gilmore JL; Gonterman RM; Menon K; Lorch G; Riese DJ; Robling A; Foley J
Mol Cancer Res; 2009 Oct; 7(10):1714-28. PubMed ID: 19825997
[TBL] [Abstract][Full Text] [Related]
4. The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation.
Dong A; Gupta A; Pai RK; Tun M; Lowe AW
J Biol Chem; 2011 May; 286(20):18301-10. PubMed ID: 21454516
[TBL] [Abstract][Full Text] [Related]
5. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.
Simbulan-Rosenthal CM; Islam N; Haribabu Y; Alobaidi R; Shalamzari A; Graham G; Kuo LW; Sykora P; Rosenthal DS
Cells; 2024 May; 13(9):. PubMed ID: 38727313
[TBL] [Abstract][Full Text] [Related]
6. Exploring the inhibitory impact of Mongolian medicinal He-Zi-3 soup on mammary gland hyperplasia in rats induced by estrogen and progestogen.
Liang C; Mu X; Bao Q; Borzigin P; Sheng H; Han X; Chen Y; Wang T
J Ethnopharmacol; 2024 Jul; 329():117854. PubMed ID: 38583733
[TBL] [Abstract][Full Text] [Related]
7. CRB3 and the FERM protein EPB41L4B regulate proliferation of mammary epithelial cells through the release of amphiregulin.
Walker SJ; Selfors LM; Margolis BL; Brugge JS
PLoS One; 2018; 13(11):e0207470. PubMed ID: 30440051
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14.
McCracken AN; Edinger AL
Biochem J; 2015 Sep; 470(3):e17-9. PubMed ID: 26341486
[TBL] [Abstract][Full Text] [Related]
9. The molecular consequences of androgen activity in the human breast.
Raths F; Karimzadeh M; Ing N; Martinez A; Yang Y; Qu Y; Lee TY; Mulligan B; Devkota S; Tilley WT; Hickey TE; Wang B; Giuliano AE; Bose S; Goodarzi H; Ray EC; Cui X; Knott SRV
Cell Genom; 2023 Mar; 3(3):100272. PubMed ID: 36950379
[TBL] [Abstract][Full Text] [Related]
10. ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.
Morato A; Accornero P; Hovey RC
J Mammary Gland Biol Neoplasia; 2023 May; 28(1):10. PubMed ID: 37219601
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland.
Ranjan M; Lee O; Cottone G; Mirzaei Mehrabad E; Spike BT; Zeng Z; Yadav S; Chatterton R; Kim JJ; Clare SE; Khan SA
Breast Cancer Res; 2021 Aug; 23(1):78. PubMed ID: 34344445
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of female sex hormones and their nuclear receptors in cervical cancer.
Lee SA; Baik S; Chung SH
Essays Biochem; 2021 Dec; 65(6):941-950. PubMed ID: 34156060
[TBL] [Abstract][Full Text] [Related]
13. Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.
Dodda BR; Bondi CD; Hasan M; Clafshenkel WP; Gallagher KM; Kotlarczyk MP; Sethi S; Buszko E; Latimer JJ; Cline JM; Witt-Enderby PA; Davis VL
Front Oncol; 2019; 9():525. PubMed ID: 31355130
[TBL] [Abstract][Full Text] [Related]
14. Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers.
Maiti S; Nazmeen A
Cancer Cell Int; 2019; 19():111. PubMed ID: 31114446
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling.
Zhao Q; Howard EW; Parris AB; Ma Z; Xing Y; Yang X
PLoS One; 2019; 14(5):e0216469. PubMed ID: 31059536
[TBL] [Abstract][Full Text] [Related]
16. IL-33 increases ST2
Halvorsen EC; Franks SE; Wadsworth BJ; Harbourne BT; Cederberg RA; Steer CA; Martinez-Gonzalez I; Calder J; Lockwood WW; Bennewith KL
Oncoimmunology; 2019; 8(2):e1527497. PubMed ID: 30713780
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
18. Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers.
Cheng M; Michalski S; Kommagani R
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154312
[TBL] [Abstract][Full Text] [Related]
19. Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells.
Scheers NM; Pereira DIA; Faria N; Powell JJ
Oncotarget; 2018 Mar; 9(24):17066-17077. PubMed ID: 29682205
[TBL] [Abstract][Full Text] [Related]
20. The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors.
Aupperlee MD; Kariagina A; Zaremba N; Basson MD; Schwartz RC; Haslam SZ
Transl Oncol; 2018 Apr; 11(2):518-527. PubMed ID: 29524829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
